United States · FDA National Drug Code directory

Telmisartan

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68462-199_7e08eda5-be87-4e09-ae4e-880a18aa7a0b
Product NDC
68462-199
Form
TABLET
Composition / generic term
Telmisartan
Labeler
Glenmark Pharmaceuticals Inc., USA
Marketing category
ANDA
Marketing start / end (source format)
20140707
Source listing expiry
20271231

Source-listed ingredients

  • TELMISARTAN — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 TABLET in 1 BOTTLE (68462-199-01) · 68462-199-01
  • 3 BLISTER PACK in 1 CARTON (68462-199-13) / 10 TABLET in 1 BLISTER PACK · 68462-199-13
  • 30 TABLET in 1 BOTTLE (68462-199-30) · 68462-199-30
  • 90 TABLET in 1 BOTTLE (68462-199-90) · 68462-199-90
  • 6 BLISTER PACK in 1 CARTON (68462-199-96) / 10 TABLET in 1 BLISTER PACK · 68462-199-96

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →